Iron Deficiency Treatment in Patients with Heart Failure.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Handbook of Experimental Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/164_2017_30PMID 28405775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absolute and Functional Iron Deficiency Is a Common Finding in Patients With Heart Failure and After Heart Transplantation.

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Estudio de la deficiencia de hierro en pacientes con insuficiencia cardiaca congestiva: una práctica clínica que precisa mayor atención

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• Iron deficiency in patients with congestive heart failure: A medical practice that requires greater attention ☆

  2016cited by this paper
• Estado del hierro en la insuficiencia cardiaca crónica: impacto en síntomas, clase funcional y capacidad de ejercicio submáxima

  2016cited by this paper
• Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials

  2016cited by this paper
• The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications

  2016cited by this paper
• Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

  2016cited by this paper
• Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure

  2016cited by this paper
• Investigation of iron deficiency in patients with congestive heart failure: A medical practice that requires greater attention.

  2016cited by this paper
• Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity.

  2016cited by this paper
• The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.

  2016cited by this paper
• Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.

  2016cited by this paper
• Iron deficiency and risk of early readmission following a hospitalization for acute heart failure

  2016cited by this paper
• Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure

  2016cited by this paper
• Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).

  2016cited by this paper
• Iron deficiency anaemia.

  2016cited by this paper
• Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.

  2015cited by this paper
• Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.

  2015cited by this paper
• Bone marrow iron depletion is common in patients with coronary artery disease.

  2015cited by this paper
• Effects of an Accelerated Intravenous Iron Regimen in Hospitalized Patients With Advanced Heart Failure and Iron Deficiency

  2015cited by this paper
• Iron Deficiency Status Irrespective of Anemia: A Predictor of Unfavorable Outcome in Chronic Heart Failure Patients

  2014cited by this paper
• Iron deficiency in a multi‐ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis

  2014cited by this paper
• Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure.

  2014cited by this paper
• Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency

  2014cited by this paper
• High prevalence of iron deficiency in patients with acute decompensated heart failure

  2014cited by this paper
• Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.

  2014cited by this paper
• Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†

  2014cited by this paper
• Inhibiting the hepcidin inhibitor for treatment of iron overload.

  2013cited by this paper
• Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.

  2013cited by this paper
• Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

  2013cited by this paper
• Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

  2013cited by this paper
• Iron status in patients with chronic heart failure.

  2013cited by this paper
• Iron deficiency in chronic heart failure: an international pooled analysis.

  2013cited by this paper
• IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.

  2013cited by this paper
• Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis.

  2013cited by this paper
• Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta‐analysis

  2012cited by this paper
• Anemia in Heart Failure: Association of Hepcidin Levels to Iron Deficiency in Stable Outpatients

  2012cited by this paper
• Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

  2012cited by this paper
• Nutritional intake and oxidative stress in chronic heart failure.

  2012cited by this paper
• Tissue Doppler and Strain Rate Imaging Detect Improvement of Myocardial Function in Iron Deficient Patients with Congestive Heart Failure after Iron Replacement Therapy

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.

  2012cited by this paper
• Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.

  2011cited by this paper
• Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

  2011cited by this paper
• Iron Deficiency in Community-Dwelling US Adults With Self-Reported Heart Failure in the National Health and Nutrition Examination Survey III: Prevalence and Associations With Anemia and Inflammation

  2011cited by this paper
• Iron homeostasis and the inflammatory response.

  2010cited by this paper
• Iron deficiency and anaemia in heart failure: understanding the FAIR‐HF trial

  2010cited by this paper
• Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

  2010cited by this paper
• Iron deficiency: an ominous sign in patients with systolic chronic heart failure.

  2010cited by this paper
• Impact of erythropoiesis‐stimulating agents on morbidity and mortality in patients with heart failure: an updated, post‐TREAT meta‐analysis

  2010cited by this paper
• Detection, evaluation, and management of iron-restricted erythropoiesis.

  2010cited by this paper
• Diagnosis and management of iron deficiency anaemia: a clinical update

  2010cited by this paper
• Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study

  2010cited by this paper
• Two to tango: regulation of Mammalian iron metabolism.

  2010cited by this paper
• Hepcidin and iron metabolism: from laboratory to clinical implications.

  2010cited by this paper
• Nutritional status and adequacy of energy and nutrient intakes among heart failure patients.

  2009cited by this paper
• Iron deficiency anemia: diagnosis and management

  2009cited by this paper
• Quality counts: new parameters in blood cell counting

  2009cited by this paper
• Estado nutricional e adequação da ingestão de energia e nutrientes em pacientes com insuficiência cardíaca

  2009cited by this paper
• Hepcidin, the iron watcher.

  2009cited by this paper
• Classification of anemia for gastroenterologists.

  2009cited by this paper
• Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005

  2009cited by this paper
• A general map of iron metabolism and tissue-specific subnetworks.

  2009cited by this paper
• Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review.

  2009cited by this paper
• Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

  2009cited by this paper
• Evolution of iv iron compounds over the last century.

  2009cited by this paper
• CLASSIFICATION OF ANEMIA FOR GASTROENTEROLOGISTS

  2009cited by this paper
• Ferric carboxymaltose in patients with heart failure and iron deficiency.

  2009cited by this paper
• The Role of Hepcidin in Iron Metabolism

  2009cited by this paper
• Iron and anemia in human biology: a review of mechanisms

  2008cited by this paper
• Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.

  2008cited by this paper
• Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

  2008cited by this paper
• Hepcidin: from discovery to differential diagnosis

  2008cited by this paper
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

  2008cited by this paper
• Nutritional iron deficiency.

  2007cited by this paper
• Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

  2007cited by this paper
• Iron uptake and metabolism in the new millennium.

  2007cited by this paper
• Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera

  2007cited by this paper
• Iron homeostasis in chronic inflammation.

  2007cited by this paper
• A precious metal: Iron, an essential nutrient for all cells

  2006cited by this paper
• Assessing iron status: beyond serum ferritin and transferrin saturation.

  2006cited by this paper
• Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

  2006cited by this paper
• Regulation of iron metabolism by hepcidin.

  2006cited by this paper
• Etiology of anemia in patients with advanced heart failure.

  2006cited by this paper
• Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.

  2006cited by this paper
• Iron deficiency: A concise review

  2005cited by this paper
• Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials.

  2005cited by this paper
• Diagnosis and management of iron-deficiency anaemia.

  2005cited by this paper
• Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis

  2005cited by this paper
• Ferritins, iron uptake and storage from the bacterioferritin viewpoint

  2003cited by this paper
• Minerals in animal and human nutrition.

  2003cited by this paper
• Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

  2002cited by this paper
• Iron biology in immune function, muscle metabolism and neuronal functioning.

  2001cited by this paper
• Iron-deficiency anemia: reexamining the nature and magnitude of the public health problem. Summary: implications for research and programs.

  2001cited by this paper
• Guidelines for the management of iron deficiency anaemia

  2000cited by this paper
• Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron.

  2000cited by this paper
• Disorders of iron metabolism.

  1999cited by this paper

• Iron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions

  2025cites this paper
• The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease

  2022cites this paper
• Prognostic role of transferrin saturation in heart failure patients.

  2021cites this paper
• In-depth review: is hepcidin a marker for the heart and the kidney?

  2021influential citation
• Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)

  2019cites this paper
• New drugs: big changes in conservative heart failure therapy?

  2019cites this paper
• Iron Deficiency Anemia

  2019cites this paper
• Heart Failure and Iron Deficiency

  2018cites this paper
• Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial

  2017cites this paper